-
Recent Posts
- Avid Bioservices Announces Addition of Novel Bacteriophage Production System at Upcoming BIO Convention as Part of a Collaboration with Phage Pharmaceuticals
- California FDB Grants Drug Manufacturing License to Phage Pharmaceuticals
- Phage Pharmaceuticals to File Investigational New Drug (IND) Application Using Its Lead Drug Candidate, FGF-1, for a First-in-Class Indication to Repair Tympanic Membrane Perforations
- Phage Pharmaceuticals and Stamford Bioprocess Technologies Sign Letter of Intent
- Phage Pharmaceuticals Executes a Letter of Intent with Viva Biotech
Archives
Categories
Monthly Archives: December 2011
Phage Pharmaceuticals to File Investigational New Drug (IND) Application Using Its Lead Drug Candidate, FGF-1, for a First-in-Class Indication to Repair Tympanic Membrane Perforations
San Diego, CA, December 20, 2011 – Phage Pharmaceuticals, a private biopharmaceutical company based in San Diego, California, announced today the submission of an IND to the US FDA to initiate a Phase 1 clinical trial of its FGF-1 drug … Continue reading